Literature DB >> 19709897

The amounts of alpha 1 antitrypsin protein are reduced in the vascular wall of the acutely dissected human ascending aorta.

Thomas Schachner1, Georg Golderer, Bettina Sarg, Herbert H Lindner, Nikolaos Bonaros, Gregor Mikuz, Guenther Laufer, Ernst R Werner.   

Abstract

BACKGROUND: Aneurysm and dissection of the ascending aorta carry the risk of life-threatening complications. The anti-protease alpha 1 antitrypsin plays an important role in the tissue protease - anti-protease equilibrium. We aim to investigate the molecular pathology of these diseases by differential proteomics and mass-spectrometric analysis.
METHODS: From ascending aortic wall specimens of aneurysms, acute dissections and controls, protein amounts were analysed by the differential in-gel electrophoresis (DIGE). Significantly, different spots underwent qualitative analysis by nanospray mass spectrometry.
RESULTS: Among the most significant differentially expressed protein spots in the DIGE analysis, the most notable protein identified by nanospray mass spectrometry was alpha 1 antitrypsin. This was significantly reduced in aneurysms and aortic dissections compared with controls (p<0.05). Western blot analysis confirmed the reduced amounts of alpha 1 antitrypsin in aortic dissections (p=0.008 vs controls) but not for aneurysms (p=0.258). By quantitative reverse transcription polymerase chain reaction (RT-PCR), mRNA level of alpha 1 antitrypsin was found to be increased in aortic dissections (p=0.035 vs controls), whereas in aneurysms a non-significant reduction of alpha 1 antitrypsin mRNA was present (p=0.123 vs controls).
CONCLUSION: In the vascular wall of ascending aortic dissections, alpha 1 antitrypsin protein amounts are reduced compared with healthy aortas. Local alpha 1 antitrypsin deficiency in the human ascending aorta might lead to proteolytic damage easing aortic dissection. Copyright (c) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19709897     DOI: 10.1016/j.ejcts.2009.07.025

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

Review 1.  Molecular mechanisms of thoracic aortic dissection.

Authors:  Darrell Wu; Ying H Shen; Ludivine Russell; Joseph S Coselli; Scott A LeMaire
Journal:  J Surg Res       Date:  2013-06-29       Impact factor: 2.192

2.  A combined proteomic and transcriptomic approach shows diverging molecular mechanisms in thoracic aortic aneurysm development in patients with tricuspid- and bicuspid aortic valve.

Authors:  Sanela Kjellqvist; Shohreh Maleki; Therese Olsson; Maggy Chwastyniak; Rui Miguel Mamede Branca; Janne Lehtiö; Florence Pinet; Anders Franco-Cereceda; Per Eriksson
Journal:  Mol Cell Proteomics       Date:  2012-11-26       Impact factor: 5.911

Review 3.  Proteomic analysis in cardiovascular research.

Authors:  Teiji Oda; Ken-ichi Matsumoto
Journal:  Surg Today       Date:  2015-04-19       Impact factor: 2.549

4.  Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population.

Authors:  Hanan Tanash; Magnus Ekström; Nawfal Basil; Eva Rönmark; Anne Lindberg; Eeva Piitulainen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-04

Review 5.  Novel Approaches for BAV Aortopathy Prediction-Is There a Need for Cohort Studies and Biomarkers?

Authors:  Evaldas Girdauskas; Johannes Petersen; Niklas Neumann; Shiho Naito; Tatiana Gross; Annika Jagodzinski; Hermann Reichenspurner; Tanja Zeller
Journal:  Biomolecules       Date:  2018-07-19

6.  Chronic Type A Aortic Dissection Repair in a Double Lung Transplant Recipient.

Authors:  Neeraj Kamat; Ragheb Traify; Brian Williams; Ioannis Dimarakis
Journal:  Aorta (Stamford)       Date:  2021-12-28

7.  Relationship Between α1-Antitrypsin Deficiency and Ascending Aortic Distention.

Authors:  Farouk Dako; Huaqing Zhao; Alexandra Mulvenna; Yogesh Sean Gupta; Scott Simpson; Friedrich Kueppers
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.